DataMeds AI, Inc. SEC filings MEDS

DataMeds AI, Inc. has 176 filings in SEC EDGAR's recent list, going back to Jul 22, 2024. Its latest annual report, Form 10-K, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (agreement ended, regulation fd disclosure). The company's fiscal year ends on December 31.

DataMeds AI, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 17, 2026 Jun 30, 2026
10-Q Quarterly report May 19, 2026 Mar 31, 2026
10-Q Quarterly report Nov 19, 2025 Sep 30, 2025
10-Q Quarterly report Aug 19, 2025 Jun 30, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025

Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as
MEDS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Tampa, FL
SEC filer status
, Emerging growth company
SEC CIK
2030763
Former names
Wellgistics Health, Inc. (until Jul 21, 2026); Danam Health, Inc (until Sep 27, 2024)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.